Horizon Therapeutics Public Limited (HZNP) Inventory Turnover Ratio, from second quarter 2023 to second quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Horizon Therapeutics Public Limited Company  (NASDAQ: HZNP)
 

Horizon Therapeutics Public Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Horizon Therapeutics Public Limited Company inventory turnover ratio, the Horizon Therapeutics Public Limited Company's ability to sell and replace its inventory in the second quarter 2023, sequentially increased to 5.2 in the second quarter 2023, HZNP's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Horizon Therapeutics Public Limited in Jun 30 2023 quarter, has decreased to 70 days, compare to 73 days, in the Mar 31 2023 quarter.

Within Healthcare sector 72 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 389, from total ranking in the first quarter 2023 at 542.

HZNP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Horizon Therapeutics Public Limited Company Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HZNP Inventory Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Inventory Growth -16.38 % -27.38 % -24.88 % -19.87 % -21.26 %
Y / Y Cost of Sales Growth -4.87 % -3.02 % -0.3 % -6.96 % 14.54 %
Inventory Turnover Ratio (TTM) 5.2 5.02 4.66 4.35 4.2
HZNP's Total Ranking # 389 # 542 # 754 # 844 # 1037
Average inventory processing period 70 73 78 84 87
Seq. Inventory Growth 3.54 % -2.99 % -10.88 % -6.59 % -10.08 %
Seq. Cost of Sales Growth 5 % -13.38 % 2.84 % 1.7 % 7.05 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 73
Overall Market # 389

Inventory Turnover Ratio Statistics
High Average Low
12.54 5.04 2.27
(Dec 31 2015)   (Dec 31 2013)



HZNP Company Profile >> Back to HZNP Efficiency Comparisons >> Compare HZNP Inventory Turnover Ratio to its Competitors

Financial Statements
Horizon Therapeutics Public Limited's Inventories $ 170 Millions Visit HZNP's Balance sheet
Horizon Therapeutics Public Limited's Cost of Revenues TTM $ 902 Millions Visit HZNP's Income Statement
What are HZNP's Sales? Visit HZNP's Sales by Segment

Other Inventory Turnover Ratios
Horizon Therapeutics Public Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HZNP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HZNP's Competitors
Inventory Turnover Ratio for HZNP's Suppliers
Inventory Turnover Ratio for HZNP's Customers

You may also want to know
HZNP's Sales Growth Rates HZNP's Pe Price to earnings ratio HZNP's Receivables Turnover Ratio HZNP's Stock Quote
HZNP's Net Income Growth Rates HZNP's Ps Price to Sales ratio HZNP's Sales per Employee HZNP's Asset Turnover Ratio
HZNP's Net Margin HZNP's Pb Price to Book ratio HZNP's Financial Strength Ratios HZNP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2023 Inventories at quarter ending Jun 30 2023
Aspira Women s Health inc   13.32 $ 3.895  Millions$ 0  Millions
Natera Inc   13.31 $ 529.903  Millions$ 40  Millions
Option Care Health Inc   13.17 $ 3,204.135  Millions$ 243  Millions
23andme Holding Co  13.04 $ 155.970  Millions$ 12  Millions
Eton Pharmaceuticals Inc   12.97 $ 7.428  Millions$ 1  Millions
Wearable Health Solutions, Inc.  12.96 $ 0.477  Millions$ 0  Millions
Lantheus Holdings Inc   12.92 $ 530.615  Millions$ 41  Millions
Precipio inc   12.72 $ 7.802  Millions$ 1  Millions
Rockwell Medical inc   12.22 $ 67.973  Millions$ 6  Millions
Qhslab Inc   11.70 $ 0.620  Millions$ 0  Millions
Rvl Pharmaceuticals Plc  11.28 $ 8.384  Millions$ 1  Millions
Sotera Health Company  10.95 $ 446.648  Millions$ 41  Millions
Agile Therapeutics Inc  10.71 $ 21.081  Millions$ 2  Millions
Myriad Genetics Inc   10.54 $ 221.300  Millions$ 21  Millions
Sunlink Health Systems Inc   10.32 $ 18.571  Millions$ 2  Millions
Infusystem Holdings Inc  10.26 $ 53.929  Millions$ 5  Millions
Puma Biotechnology Inc   10.12 $ 54.406  Millions$ 5  Millions
Genedx Holdings Corp   10.00 $ 204.264  Millions$ 20  Millions
Cryo cell International Inc   9.80 $ 8.698  Millions$ 1  Millions
Semler Scientific inc   9.77 $ 4.807  Millions$ 0  Millions
Irhythm Holdings Inc   9.24 $ 139.619  Millions$ 15  Millions
Dermtech Inc   9.13 $ 13.865  Millions$ 2  Millions
Prophase Labs Inc   8.93 $ 37.550  Millions$ 4  Millions
Bionexus Gene Lab Corp   8.67 $ 8.968  Millions$ 1  Millions
Kaya Holdings Inc   8.64 $ 0.139  Millions$ 0  Millions
Castle Biosciences Inc   8.60 $ 39.619  Millions$ 5  Millions
Charles River Laboratories International inc   8.55 $ 2,277.407  Millions$ 266  Millions
Camp4 Therapeutics Corporation  8.20 $ 190.689  Millions$ 23  Millions
Cardiff Lexington Corporation  7.95 $ 4.293  Millions$ 1  Millions
Kewaunee Scientific Corporation  7.87 $ 176.979  Millions$ 22  Millions

Date modified: 2026-09-08T15:22:11+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.